TVEC and Preop Radiation for Sarcoma (8 ml Dose)

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

February 7, 2023

Study Completion Date

November 7, 2027

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Talimogene Laherparepvec

Talimogene Laherparepvec

RADIATION

Radiotherapy

Concurrent Preoperative Radiation. External Beam Radiation Therapy (EBRT) will be given at the standard dose for resectable soft tissue sarcomas. according to the NCCN sarcoma guidelines.

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

John Rieth

OTHER